Lallemand Health Solutions joins forces with the French Gut Project to accelerate microbiome science, innovation

An initiative of the MetaGenoPolis unit of INRAE (the National Research Institute for Agriculture, Food and the Environment), the French Gut Project is a research project that has set out to collect 100,000 French intestinal metagenomes for analysis

Lallemand Health Solutions (Mirabel, Canada) partnered with the French Gut Project. An initiative of the MetaGenoPolis unit of INRAE (the National Research Institute for Agriculture, Food and the Environment), the French Gut Project is a research project that has set out to collect 100,000 French intestinal metagenomes for analysis, including the associated nutritional and clinical data, to accelerate microbiota science and innovation.

“The French Gut is a national contribution on the microbiota with the ambition of mapping and understanding the heterogeneity of the composition of the intestinal microbiota in healthy people, the factors that impact them, as well as their deviations in chronic diseases,” explained Joël Doré, INRAE,​​ research director and scientific director of MetaGenoPolis-INRAE, in a press release. “By 2027, the stools of 100,000 volunteers as well as the associated nutritional and clinical data will be collected to deepen knowledge of the links between microbiota, diet, and lifestyle. The French Gut will make it possible, from the scientific knowledge generated, to move towards personalized preventive nutrition. It will also pave the way for innovative diagnostics and therapies, particularly in the context of chronic diseases which have been increasing steadily and uncontrollably for three generations. It will also raise awareness among the public, adults, and children, about the microbiota and its link with health and food.”

The French Gut is also part of the international project, Million Microbiome of Humans Project (MMHP), which brings together several research institutes around the world to constitute the largest global database of human microbiota with a million of samples.

“Describing and understanding the key role micro-organisms play for human health is at the heart of Lallemand Health Solutions’ DNA,” said Sylvie Binda, vice president, research, and development at Lallemand Health Solutions, in a press release. “On this ground we joined this ambitious project to map the intestinal microbiota of French people. This new encyclopedia will open up a huge field of exploration of the potential of the microbiota to help international research on new health solutions.”